GoodRx (Foundayo + Zepbound KwikPen) Review
Best for: self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. As of April 9, 2026, GoodRx is offering self-pay pricing for Eli Lilly's new oral GLP-1 Foundayo (orforglipron) starting at $149/month and Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide via the GoodRx discount card.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
GoodRx (Foundayo + Zepbound KwikPen) is one of the most affordable GLP-1 options on the market.
Score Breakdown
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Foundayo (lowest dose, self-pay) | brand | $149 |
| Zepbound KwikPen (self-pay) | brand | $299 |
✓ Pros
- •$149/month self-pay price for FDA-approved brand-name Foundayo (orforglipron) — matches the lowest available discounted cash price at launch and is dramatically cheaper than typical retail brand-GLP-1 pricing
- •$299/month self-pay for FDA-approved Zepbound KwikPen — significantly under the typical Lilly cash list price
- •Honored at 70,000+ US pharmacies nationwide — by far the largest brick-and-mortar redemption network of any GLP-1 distribution channel we cover
- •No telehealth membership fee — you bring your own prescription and present the discount card at the pharmacy counter
- •Brand-name FDA-approved medication, not compounded — no compounding-pharmacy quality variability or FDA non-evaluation disclaimer
- •Pharmaceutical manufacturer-direct pricing model — Lilly is delivering the discounted cash price directly through GoodRx, not a third-party negotiation
✗ Cons
- •Requires a valid prescription — GoodRx is a discount card, not a telehealth provider. You still need a clinician to write the script (your existing PCP, an endocrinologist, or a separate telehealth visit)
- •Self-pay only — does not coordinate with insurance benefits or apply toward insurance deductibles
- •Pricing applies only to the lowest Foundayo dose at the headline number; higher doses may carry different pricing not disclosed in the launch
- •Does not include compounded GLP-1s — if you want compounded semaglutide or tirzepatide, this is not the channel
- •GoodRx is publicly traded (NASDAQ: GDRX) and pricing is subject to change as Lilly's manufacturer-sponsored coupon program evolves
Ready to start with GoodRx (Foundayo + Zepbound KwikPen)?
Starting at $149/month. See current pricing and start your free consultation.
Sources & methodology
Our GoodRx (Foundayo + Zepbound KwikPen) review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 7.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to GoodRx (Foundayo + Zepbound KwikPen)
Alan Meds
Best for: budget-conscious shoppers
Editorial score · methodology
Amazon Pharmacy
Best for: fastest brand-name Foundayo delivery with the cheapest insured price
Editorial score · methodology
AmberHealth
Best for: budget-conscious shoppers
Editorial score · methodology
Frequently Asked Questions
Ready to start with GoodRx (Foundayo + Zepbound KwikPen)?
Starting at $149/month. See current pricing and start your free consultation.